United States Radiopharmaceuticals Market Report & Forecast 2021-2027

United States Radiopharmaceuticals Market Report & Forecast 2021-2027

Table of Contents
1 Introduction to Research & Analysis Reports
1.1 Radiopharmaceuticals Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 United States Radiopharmaceuticals Market Overview
1.4 Methodology & Sources of Information
1.4.1 Research Methodology
1.4.2 Research Process
1.4.3 Base Year
2 United States Radiopharmaceuticals Overall Market Size
2.1 United States Radiopharmaceuticals Market Size: 2021 VS 2027
2.2 United States Radiopharmaceuticals Revenue, Prospects & Forecasts: 2016-2027
2.3 United States Radiopharmaceuticals Sales: 2016-2027
3 Company Landscape
3.1 Top Radiopharmaceuticals Players in United States Market
3.2 Top United States Radiopharmaceuticals Companies Ranked by Revenue
3.3 United States Radiopharmaceuticals Revenue by Companies
3.4 United States Radiopharmaceuticals Sales by Companies
3.5 United States Radiopharmaceuticals Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Radiopharmaceuticals Companies in United States Market, by Revenue in 2020
3.7 Manufacturers Radiopharmaceuticals Product Type
3.8 Tier 1, Tier 2 and Tier 3 Radiopharmaceuticals Players in United States Market
3.8.1 List of Tier 1 Radiopharmaceuticals Companies in United States
3.8.2 List of Tier 2 and Tier 3 Radiopharmaceuticals Companies in United States
4 Sights by Type
4.1 Overview
4.1.1 By Type - United States Radiopharmaceuticals Market Size Markets, 2021 & 2027
4.1.2 Diagnostic Radioisotopes
4.1.3 Therapeutic Radioisotopes
4.2 By Type - United States Radiopharmaceuticals Revenue & Forecasts
4.2.1 By Type - United States Radiopharmaceuticals Revenue, 2016-2021
4.2.2 By Type - United States Radiopharmaceuticals Revenue, 2022-2027
4.2.3 By Type - United States Radiopharmaceuticals Revenue Market Share, 2016-2027
4.3 By Type - United States Radiopharmaceuticals Sales & Forecasts
4.3.1 By Type - United States Radiopharmaceuticals Sales, 2016-2021
4.3.2 By Type - United States Radiopharmaceuticals Sales, 2022-2027
4.3.3 By Type - United States Radiopharmaceuticals Sales Market Share, 2016-2027
4.4 By Type - United States Radiopharmaceuticals Price (Manufacturers Selling Prices), 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - United States Radiopharmaceuticals Market Size, 2021 & 2027
5.1.2 Oncology
5.1.3 Cardiology
5.1.4 Other
5.2 By Application - United States Radiopharmaceuticals Revenue & Forecasts
5.2.1 By Application - United States Radiopharmaceuticals Revenue, 2016-2021
5.2.2 By Application - United States Radiopharmaceuticals Revenue, 2022-2027
5.2.3 By Application - United States Radiopharmaceuticals Revenue Market Share, 2016-2027
5.3 By Application - United States Radiopharmaceuticals Sales & Forecasts
5.3.1 By Application - United States Radiopharmaceuticals Sales, 2016-2021
5.3.2 By Application - United States Radiopharmaceuticals Sales, 2022-2027
5.3.3 By Application - United States Radiopharmaceuticals Sales Market Share, 2016-2027
5.4 By Application - United States Radiopharmaceuticals Price (Manufacturers Selling Prices), 2016-2027
6 Manufacturers & Brands Profiles
6.1 Bracco Imaging
6.1.1 Bracco Imaging Corporation Information
6.1.2 Bracco Imaging Overview
6.1.3 Bracco Imaging Radiopharmaceuticals Sales and Revenue in United States Market (2016-2021)
6.1.4 Bracco Imaging Radiopharmaceuticals Product Description
6.1.5 Bracco Imaging Recent Developments
6.2 Bayer
6.2.1 Bayer Corporation Information
6.2.2 Bayer Overview
6.2.3 Bayer Radiopharmaceuticals Sales and Revenue in United States Market (2016-2021)
6.2.4 Bayer Radiopharmaceuticals Product Description
6.2.5 Bayer Recent Developments
6.3 Mallinckrodt
6.3.1 Mallinckrodt Corporation Information
6.3.2 Mallinckrodt Overview
6.3.3 Mallinckrodt Radiopharmaceuticals Sales and Revenue in United States Market (2016-2021)
6.3.4 Mallinckrodt Radiopharmaceuticals Product Description
6.3.5 Mallinckrodt Recent Developments
6.4 Nordion
6.4.1 Nordion Corporation Information
6.4.2 Nordion Overview
6.4.3 Nordion Radiopharmaceuticals Sales and Revenue in United States Market (2016-2021)
6.4.4 Nordion Radiopharmaceuticals Product Description
6.4.5 Nordion Recent Developments
6.5 Triad Isotopes
6.5.1 Triad Isotopes Corporation Information
6.5.2 Triad Isotopes Overview
6.5.3 Triad Isotopes Radiopharmaceuticals Sales and Revenue in United States Market (2016-2021)
6.5.4 Triad Isotopes Radiopharmaceuticals Product Description
6.5.5 Triad Isotopes Recent Developments
6.6 Lantheus
6.6.1 Lantheus Corporation Information
6.6.2 Lantheus Overview
6.6.3 Lantheus Radiopharmaceuticals Sales and Revenue in United States Market (2016-2021)
6.6.4 Lantheus Radiopharmaceuticals Product Description
6.6.5 Lantheus Recent Developments
6.7 IBA Group
6.7.1 IBA Group Corporation Information
6.7.2 IBA Group Overview
6.7.3 IBA Group Radiopharmaceuticals Sales and Revenue in United States Market (2016-2021)
6.7.4 IBA Group Radiopharmaceuticals Product Description
6.7.5 IBA Group Recent Developments
6.8 GE Healthcare
6.8.1 GE Healthcare Corporation Information
6.8.2 GE Healthcare Overview
6.8.3 GE Healthcare Radiopharmaceuticals Sales and Revenue in United States Market (2016-2021)
6.8.4 GE Healthcare Radiopharmaceuticals Product Description
6.8.5 GE Healthcare Recent Developments
6.9 China Isotope & Radiation
6.9.1 China Isotope & Radiation Corporation Information
6.9.2 China Isotope & Radiation Overview
6.9.3 China Isotope & Radiation Radiopharmaceuticals Sales and Revenue in United States Market (2016-2021)
6.9.4 China Isotope & Radiation Radiopharmaceuticals Product Description
6.9.5 China Isotope & Radiation Recent Developments
6.10 Jubilant Pharma
6.10.1 Jubilant Pharma Corporation Information
6.10.2 Jubilant Pharma Overview
6.10.3 Jubilant Pharma Radiopharmaceuticals Sales and Revenue in United States Market (2016-2021)
6.10.4 Jubilant Pharma Radiopharmaceuticals Product Description
6.10.5 Jubilant Pharma Recent Developments
6.11 Eli Lilly
6.11.1 Eli Lilly Corporation Information
6.11.2 Eli Lilly Overview
6.11.3 Eli Lilly Radiopharmaceuticals Sales and Revenue in United States Market (2016-2021)
6.11.4 Eli Lilly Radiopharmaceuticals Product Description
6.11.5 Eli Lilly Recent Developments
6.12 Advanced Accelerator Applications
6.12.1 Advanced Accelerator Applications Corporation Information
6.12.2 Advanced Accelerator Applications Overview
6.12.3 Advanced Accelerator Applications Radiopharmaceuticals Sales and Revenue in United States Market (2016-2021)
6.12.4 Advanced Accelerator Applications Radiopharmaceuticals Product Description
6.12.5 Advanced Accelerator Applications Recent Developments
6.13 SIEMENS
6.13.1 SIEMENS Corporation Information
6.13.2 SIEMENS Overview
6.13.3 SIEMENS Radiopharmaceuticals Sales and Revenue in United States Market (2016-2021)
6.13.4 SIEMENS Radiopharmaceuticals Product Description
6.13.5 SIEMENS Recent Developments
6.14 Dongcheng
6.14.1 Dongcheng Corporation Information
6.14.2 Dongcheng Overview
6.14.3 Dongcheng Radiopharmaceuticals Sales and Revenue in United States Market (2016-2021)
6.14.4 Dongcheng Radiopharmaceuticals Product Description
6.14.5 Dongcheng Recent Developments
6.15 Navidea
6.15.1 Navidea Corporation Information
6.15.2 Navidea Overview
6.15.3 Navidea Radiopharmaceuticals Sales and Revenue in United States Market (2016-2021)
6.15.4 Navidea Radiopharmaceuticals Product Description
6.15.5 Navidea Recent Developments
7 United States Radiopharmaceuticals Production Capacity, Analysis
7.1 United States Radiopharmaceuticals Production Capacity, 2016-2027
7.2 Radiopharmaceuticals Production Capacity of Key Manufacturers in United States Market
8 Key Market Trends, Opportunity, Drivers and Restraints
8.1 Market Opportunities & Trends
8.2 Market Drivers
8.3 Market Restraints
9 Radiopharmaceuticals Supply Chain Analysis
9.1 Radiopharmaceuticals Industry Value Chain
9.2 Radiopharmaceuticals Upstream Market
9.3 Radiopharmaceuticals Downstream and Clients
9.4 Marketing Channels Analysis
9.4.1 Marketing Channels
9.4.2 Radiopharmaceuticals Distributors and Sales Agents in United States Market
10 Conclusion
11 Appendix
11.1 Note
11.2 Examples of Clients
11.3 Author Details
11.4 Disclaimer
List of Tables
Table 1. Key Players of Radiopharmaceuticals in United States Market
Table 2. Top Radiopharmaceuticals Players in United States Market, Ranking by Revenue (2019)
Table 3. United States Radiopharmaceuticals Revenue by Companies, (US$, Mn), 2016-2021
Table 4. United States Radiopharmaceuticals Revenue Share by Companies, 2016-2021
Table 5. United States Radiopharmaceuticals Sales by Companies, (K Dose), 2016-2021
Table 6. United States Radiopharmaceuticals Sales Share by Companies, 2016-2021
Table 7. Key Manufacturers Radiopharmaceuticals Price (2016-2021) & (US$/Dose)
Table 8. Manufacturers Radiopharmaceuticals Product Type
Table 9. List of Tier 1 Radiopharmaceuticals Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Tier 2 and Tier 3 Radiopharmaceuticals Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. Major Manufacturers of Diagnostic Radioisotopes
Table 12. Major Manufacturers of Therapeutic Radioisotopes
Table 13. By Type - United States Radiopharmaceuticals Revenue, (US$, Mn), 2021 & 2027
Table 14. By Type - United States Radiopharmaceuticals Revenue (US$, Mn), 2016-2021
Table 15. By Type - United States Radiopharmaceuticals Revenue (US$, Mn), 2022-2027
Table 16. By Type - United States Radiopharmaceuticals Sales (K Dose), 2016-2021
Table 17. By Type - United States Radiopharmaceuticals Sales (K Dose), 2022-2027
Table 18. By Application - United States Radiopharmaceuticals Revenue, (US$, Mn), 2021 VS 2027
Table 19. By Application - United States Radiopharmaceuticals Revenue (US$, Mn), 2016-2021
Table 20. By Application - United States Radiopharmaceuticals Revenue (US$, Mn), 2022-2027
Table 21. By Application - United States Radiopharmaceuticals Sales (K Dose), 2016-2021
Table 22. By Application - United States Radiopharmaceuticals Sales (K Dose), 2022-2027
Table 23. Bracco Imaging Corporation Information
Table 24. Bracco Imaging Description and Major Businesses
Table 25. Bracco Imaging Radiopharmaceuticals Sales (K Dose), Revenue (US$, Mn) and Gross Margin (US$/Dose) (2016-2021)
Table 26. Bracco Imaging Radiopharmaceuticals Product
Table 27. Bracco Imaging Recent Developments
Table 28. Bayer Corporation Information
Table 29. Bayer Description and Major Businesses
Table 30. Bayer Radiopharmaceuticals Sales (K Dose), Revenue (US$, Mn) and Gross Margin (US$/Dose) (2016-2021)
Table 31. Bayer Radiopharmaceuticals Product
Table 32. Bayer Recent Developments
Table 33. Mallinckrodt Corporation Information
Table 34. Mallinckrodt Description and Major Businesses
Table 35. Mallinckrodt Radiopharmaceuticals Sales (K Dose), Revenue (US$, Mn) and Gross Margin (US$/Dose) (2016-2021)
Table 36. Mallinckrodt Radiopharmaceuticals Product
Table 37. Mallinckrodt Recent Developments
Table 38. Nordion Corporation Information
Table 39. Nordion Description and Major Businesses
Table 40. Nordion Radiopharmaceuticals Sales (K Dose), Revenue (US$, Mn) and Gross Margin (US$/Dose) (2016-2021)
Table 41. Nordion Radiopharmaceuticals Product
Table 42. Nordion Recent Developments
Table 43. Triad Isotopes Corporation Information
Table 44. Triad Isotopes Description and Major Businesses
Table 45. Triad Isotopes Radiopharmaceuticals Sales (K Dose), Revenue (US$, Mn) and Gross Margin (US$/Dose) (2016-2021)
Table 46. Triad Isotopes Radiopharmaceuticals Product
Table 47. Triad Isotopes Recent Developments
Table 48. Lantheus Corporation Information
Table 49. Lantheus Description and Major Businesses
Table 50. Lantheus Radiopharmaceuticals Sales (K Dose), Revenue (US$, Mn) and Gross Margin (US$/Dose) (2016-2021)
Table 51. Lantheus Radiopharmaceuticals Product
Table 52. Lantheus Recent Developments
Table 53. IBA Group Corporation Information
Table 54. IBA Group Description and Major Businesses
Table 55. IBA Group Radiopharmaceuticals Sales (K Dose), Revenue (US$, Mn) and Gross Margin (US$/Dose) (2016-2021)
Table 56. IBA Group Radiopharmaceuticals Product
Table 57. IBA Group Recent Developments
Table 58. GE Healthcare Corporation Information
Table 59. GE Healthcare Description and Major Businesses
Table 60. GE Healthcare Radiopharmaceuticals Sales (K Dose), Revenue (US$, Mn) and Gross Margin (US$/Dose) (2016-2021)
Table 61. GE Healthcare Radiopharmaceuticals Product
Table 62. GE Healthcare Recent Developments
Table 63. China Isotope & Radiation Corporation Information
Table 64. China Isotope & Radiation Description and Major Businesses
Table 65. China Isotope & Radiation Radiopharmaceuticals Sales (K Dose), Revenue (US$, Mn) and Gross Margin (US$/Dose) (2016-2021)
Table 66. China Isotope & Radiation Radiopharmaceuticals Product
Table 67. China Isotope & Radiation Recent Developments
Table 68. Jubilant Pharma Corporation Information
Table 69. Jubilant Pharma Description and Major Businesses
Table 70. Jubilant Pharma Radiopharmaceuticals Sales (K Dose), Revenue (US$, Mn) and Gross Margin (US$/Dose) (2016-2021)
Table 71. Jubilant Pharma Radiopharmaceuticals Product
Table 72. Jubilant Pharma Recent Developments
Table 73. Eli Lilly Corporation Information
Table 74. Eli Lilly Description and Major Businesses
Table 75. Eli Lilly Radiopharmaceuticals Sales (K Dose), Revenue (US$, Mn) and Gross Margin (US$/Dose) (2016-2021)
Table 76. Eli Lilly Radiopharmaceuticals Product
Table 77. Eli Lilly Recent Developments
Table 78. Advanced Accelerator Applications Corporation Information
Table 79. Advanced Accelerator Applications Description and Major Businesses
Table 80. Advanced Accelerator Applications Radiopharmaceuticals Sales (K Dose), Revenue (US$, Mn) and Gross Margin (US$/Dose) (2016-2021)
Table 81. Advanced Accelerator Applications Radiopharmaceuticals Product
Table 82. Advanced Accelerator Applications Recent Developments
Table 83. SIEMENS Corporation Information
Table 84. SIEMENS Description and Major Businesses
Table 85. SIEMENS Radiopharmaceuticals Sales (K Dose), Revenue (US$, Mn) and Gross Margin (US$/Dose) (2016-2021)
Table 86. SIEMENS Radiopharmaceuticals Product
Table 87. SIEMENS Recent Developments
Table 88. Dongcheng Corporation Information
Table 89. Dongcheng Description and Major Businesses
Table 90. Dongcheng Radiopharmaceuticals Sales (K Dose), Revenue (US$, Mn) and Gross Margin (US$/Dose) (2016-2021)
Table 91. Dongcheng Radiopharmaceuticals Product
Table 92. Dongcheng Recent Developments
Table 93. Navidea Corporation Information
Table 94. Navidea Description and Major Businesses
Table 95. Navidea Radiopharmaceuticals Sales (K Dose), Revenue (US$, Mn) and Gross Margin (US$/Dose) (2016-2021)
Table 96. Navidea Radiopharmaceuticals Product
Table 97. Navidea Recent Developments
Table 98. Radiopharmaceuticals Production Capacity (K Dose) of Key Manufacturers in United States Market, 2019-2021 (K Dose)
Table 99. United States Radiopharmaceuticals Capacity Market Share of Key Manufacturers, 2019-2021
Table 100. Radiopharmaceuticals Market Opportunities & Trends in United States Market
Table 101. Radiopharmaceuticals Market Drivers in United States Market
Table 102. Radiopharmaceuticals Market Restraints in United States Market
Table 103. Radiopharmaceuticals Raw Materials
Table 104. Radiopharmaceuticals Raw Materials Suppliers in United States Market
Table 105. Typical Radiopharmaceuticals Downstream
Table 106. Radiopharmaceuticals Downstream Clients in United States Market
Table 107. Radiopharmaceuticals Distributors and Sales Agents in United States Market
List of Figures
Figure 1. Radiopharmaceuticals Product Picture
Figure 2. Radiopharmaceuticals Segment by Type
Figure 3. Radiopharmaceuticals Segment by Application
Figure 4. United States Radiopharmaceuticals Market Overview: 2020
Figure 5. United States Radiopharmaceuticals Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. United States Radiopharmaceuticals Revenue, 2016-2027 (US$, Mn)
Figure 7. Radiopharmaceuticals Sales in United States Market: 2016-2027 (K Dose)
Figure 8. The Top 3 and 5 Players Market Share by Radiopharmaceuticals Revenue in 2020
Figure 9. Diagnostic Radioisotopes Product Picture
Figure 10. Therapeutic Radioisotopes Product Picture
Figure 11. By Type - United States Radiopharmaceuticals Sales Market Share, 2016-2027
Figure 12. By Type - United States Radiopharmaceuticals Revenue Market Share, 2016-2027
Figure 13. By Type - United States Radiopharmaceuticals Price (US$/Dose), 2016-2027
Figure 14. Oncology
Figure 15. Cardiology
Figure 16. Other
Figure 17. By Application - United States Radiopharmaceuticals Sales Market Share, 2016-2027
Figure 18. By Application - United States Radiopharmaceuticals Revenue Market Share, 2016-2027
Figure 19. By Application - United States Radiopharmaceuticals Price (US$/Dose), 2016-2027
Figure 20. Bracco Imaging Radiopharmaceuticals Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 21. Bayer Radiopharmaceuticals Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 22. Mallinckrodt Radiopharmaceuticals Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 23. Nordion Radiopharmaceuticals Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 24. Triad Isotopes Radiopharmaceuticals Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 25. Lantheus Radiopharmaceuticals Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 26. IBA Group Radiopharmaceuticals Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 27. GE Healthcare Radiopharmaceuticals Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 28. China Isotope & Radiation Radiopharmaceuticals Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 29. Jubilant Pharma Radiopharmaceuticals Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 30. Eli Lilly Radiopharmaceuticals Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 31. Advanced Accelerator Applications Radiopharmaceuticals Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 32. SIEMENS Radiopharmaceuticals Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 33. Dongcheng Radiopharmaceuticals Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 34. Navidea Radiopharmaceuticals Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 35. United States Radiopharmaceuticals Production Capacity (K Dose), 2016-2027
Figure 36. Radiopharmaceuticals Industry Value Chain
Figure 37. Marketing Channels

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Radiopharmaceutical Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 125

According to our LPI (LP Information) latest study, the global Radiopharmaceutical market size was valued at US$ 6613.9 million in 2023. With growing demand in downstream market, the Radiopharmaceutical is forecast to a readjusted size of US$ 11560 million by 2030 with a CAGR of 8.3% during review period. The research report highlights the growth potential of the global Radiopharmaceutical market. Radiopharmaceutical are expected to show stable growth in the future market. However, produ......

Global Radiopharmaceuticals Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 138

According to our LPI (LP Information) latest study, the global Radiopharmaceuticals market size was valued at US$ 6613.9 million in 2023. With growing demand in downstream market, the Radiopharmaceuticals is forecast to a readjusted size of US$ 11560 million by 2030 with a CAGR of 8.3% during review period. The research report highlights the growth potential of the global Radiopharmaceuticals market. Radiopharmaceuticals are expected to show stable growth in the future market. However, p......

Global Radiopharmaceutical Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 137

According to our (Global Info Research) latest study, the global Radiopharmaceutical market size was valued at USD 6956.7 million in 2023 and is forecast to a readjusted size of USD 11660 million by 2030 with a CAGR of 7.7% during review period. Radiopharmaceuticals are radioactive compounds administered to the patient, and monitored via specific imaging devices, for diagnosis and therapeutic purposes. It is composed of a radioisotope bond to an organic molecule. The organic molecule con......

Global Radiation Dose Management Market Research Report 2023

Published: 28-Dec-2023        Price: US 2900 Onwards        Pages: 88

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Radiation Dose Management market with multiple angles, which provides sufficient supports to readers' strategy and decision making. By Company - Landauer - Sectra AB - Afga-Gevaert - INFINITT Healthcare - Bayer Healthcare - PACSHealth - Koninklijke Philips - GE Healthcar......

Global Radiation Dose Management Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 21-Dec-2023        Price: US 3380 Onwards        Pages: 111

Market Overview of Global Radiation Dose Management market: According to our latest research, the global Radiation Dose Management market looks promising in the next 5 years. As of 2022, the global Radiation Dose Management market was estimated at USD 484.67 million, and it's anticipated to reach USD 1069.95 million in 2028, with a CAGR of 14.11% during the forecast years. The radiation dose management channel includes information of radiation dose recording software, real-ti......

Global Radiation Dose Management Market Research Report 2024 (Status and Outlook)

Published: 15-Dec-2023        Price: US 3200 Onwards        Pages: 124

Report Overview: The Global Radiation Dose Management Market Size was estimated at USD 862.70 million in 2022 and is projected to reach USD 3695.44 million by 2029, exhibiting a CAGR of 23.10% during the forecast period. This report provides a deep insight into the global Radiation Dose Management market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche marke......

Global Radiopharmaceutical Professional Survey Report 2023, Forecast to 2028

Published: 21-Nov-2023        Price: US 3280 Onwards        Pages: 133

Radiopharmaceuticals are unique medicinal formulations containing radioisotopes which are used in major clinical areas for diagnosis and/or therapy. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technological adv......

Global Radiopharmaceutical Market Research Report 2023, Forecast to 2028

Published: 21-Nov-2023        Price: US 2680 Onwards        Pages: 166

Radiopharmaceuticals are unique medicinal formulations containing radioisotopes which are used in major clinical areas for diagnosis and/or therapy. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technological adv......

Global Radiopharmaceutical Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 14-Nov-2023        Price: US 3380 Onwards        Pages: 116

Market Overview of Global Radiopharmaceutical market: According to our latest research, the global Radiopharmaceutical market looks promising in the next 5 years. As of 2022, the global Radiopharmaceutical market was estimated at USD 7319.21 million, and it's anticipated to reach USD 13640.5 million in 2028, with a CAGR of 10.93% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global R......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs